Search for: "Novartis Pharmaceuticals Corp"
Results 201 - 220
of 367
Sort by Relevance
|
Sort by Date
2 May 2011, 6:17 am
Novartis Pharmaceuticals Corp., No. 06-Civ-0260 (BMC) (EDNY April 24, 2011). [read post]
26 Mar 2011, 10:17 am
Similar lawsuits have been filed recently against other major companies: Publicis Group S.A., the U.S. business and French advertising company for Toshiba Corp.; Goldman Sachs Group Inc.; and the U.S. unit of Novartis AG. [read post]
16 Mar 2011, 3:50 am
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
15 Mar 2011, 1:31 pm
Novartis Pharmaceuticals Corp., 2011 U.S. [read post]
14 Mar 2011, 9:25 pm
Two pharmaceutical giants - Novartis Pharmaceuticals and Schering Corp - may have exhausted their legal remedies to fight the Second Circuit's decision. [read post]
11 Mar 2011, 8:09 am
On February 28, 2011, the United States Supreme Court denied the petition by Novartis and Schering Corp. to review the decision. [read post]
8 Mar 2011, 6:57 am
Just weeks after the Ninth Circuit created a circuit split by ruling that pharmaceutical sales representatives are exempt under the Fair Labor Standards Act's outside sales exemption (see our earlier post on that decision), the Supreme Court has declined to hear Novartis Pharmaceutical Corp.'s appeal of a Second Circuit decision reaching the opposite conclusion. [read post]
1 Mar 2011, 1:34 pm
Kuzinski (No. 10-459) and Novartis Pharmaceuticals Corp. v. [read post]
1 Mar 2011, 4:09 am
Novartis Pharmaceuticals Corp. v. [read post]
25 Feb 2011, 1:26 pm
KuzinskiDocket: 10-459Issue(s): (1) What deference is due to an agency interpretation of its own regulations when the interpretation departs from the agency’s prior position; and (2) whether the Second Circuit erred in its construction of the outside sales exemption of the Fair Labor Standards Act.Certiorari stage documents:Opinion below (2d Cir.)Petition for certiorariBrief in oppositionPetitioner's reply Title: Novartis Pharmaceuticals Corp. v. [read post]
23 Feb 2011, 9:52 am
§ Petition for certiorari § Brief in opposition § Petitioner’s reply Title: Novartis Pharmaceuticals Corp. v. [read post]
18 Feb 2011, 1:38 am
Title: Schering Corp. v. [read post]
15 Feb 2011, 10:44 am
Until the Secretary's appearance in Novartis, the DOL did not challenge the conventional wisdom that detailing is the functional equivalent of selling pharmaceutical products. [read post]
15 Feb 2011, 5:48 am
SmithKline Beecham Corp. were pharmaceutical sales representatives. [read post]
15 Feb 2011, 4:06 am
SmithKline Beecham Corp. [read post]
13 Feb 2011, 9:08 pm
Novartis Pharmaceuticals Corp. et al. v. [read post]
5 Jan 2011, 9:22 am
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010. [read post]
3 Jan 2011, 5:49 am
Novartis Pharmaceuticals Corp., 2010 MT 282 (Montana December 30, 2010), adds to this Winter of discontent. [read post]
31 Dec 2010, 11:31 am
Novartis Pharmaceuticals Corp., DA 10-0029 slip op., at 30 (Mont. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
